Aug 1 |
Regeneron Pharmaceuticals' Q2 Earnings Exceed Estimates, Driven By Its Top-Selling Eczema And Eye Drugs
|
Aug 1 |
Defensive Sectors Breakout: 3 Stocks to Buy Now for Protection
|
Aug 1 |
Regeneron Pharmaceuticals, Inc. (REGN) Q2 2024 Earnings Call Transcript
|
Aug 1 |
Compared to Estimates, Regeneron (REGN) Q2 Earnings: A Look at Key Metrics
|
Aug 1 |
Regeneron (REGN) Tops on Q2 Earnings, Eylea HD, Dupixent Fuel Sales
|
Aug 1 |
Regeneron beats quarterly results on strong demand for eczema, eye treatments
|
Aug 1 |
Regeneron beats in Q2 as Eylea tops expectations
|
Aug 1 |
Regeneron Stock Climbs After Strong Second-Quarter Performance
|
Aug 1 |
Regeneron (REGN) Surpasses Q2 Earnings and Revenue Estimates
|
Aug 1 |
Wall Street Looks To Ride On Earnings Cheer As Meta Q2 Impresses Investors: Analyst Says Economic Data, Stock Performances Suggest Republican Win In November
|